Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study
Background There are no primary prevention trials of aspirin with relevant geriatric outcomes in elderly people. ASPirin in Reducing Events in the Elderly (ASPREE) is a placebo-controlled trial of low-dose aspirin that will determine whether 5 years of daily 100-mg enteric-coated aspirin extends disability-free and dementia-free life in a healthy elderly population and whether these benefits outweigh the risks. Methods Set in primary care, this randomized double-blind placebo-controlled...[Show more]
|Collections||ANU Research Publications|
|Source:||Journals of Gerontology Series A: Biological Sciences and Medical Sciences|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.